Health Insurance and Colorectal Cancer Survival in Khon Kaen, Thailand.
Colorectal Neoplasms
/ economics
Female
Follow-Up Studies
Health Services Accessibility
Humans
Insurance Coverage
/ statistics & numerical data
Insurance, Health
/ statistics & numerical data
Male
Middle Aged
Prognosis
Registries
/ statistics & numerical data
Retrospective Studies
Socioeconomic Factors
Survival Rate
Thailand
Universal Health Insurance
/ statistics & numerical data
Health Insurance
colorectal cancer
relative survival
Journal
Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625
Informations de publication
Date de publication:
01 06 2019
01 06 2019
Historique:
received:
17
12
2018
entrez:
28
6
2019
pubmed:
28
6
2019
medline:
19
12
2019
Statut:
epublish
Résumé
Background: Evidence from healthcare studies demonstrates that patients’ health insurance affects service
accessibility and the outcome of treatment. However, assessment on how colorectal cancer survival relates to health
insurance is limited. Objective: The study examined the association between health insurance and colorectal cancer
survival in Khon Kaen, Thailand. Methods: The retrospective cohort study was conducted with 1,931 colorectal cancer
patients from Khon Kaen cancer registry between January 1, 2003 and December 31, 2012, and was followed-up until
December 31, 2015. Relative survival was used to estimate the survival rate. Cox proportional hazard regression was
used to estimate the relationship between health insurance and colorectal cancer survival, represented with the hazard
ratio. Result: Most of the participants were males, and the median age was 62 years. The median survival time was
2.25 years (95% CI: 2.00-2.51). The five-year observed survival rate and relative survival rate were 36.87 (95% CI:
34.66-39.08) and, 42.28 (95% CI: 39.75-44.81), respectively. The factors that showed significant associations with
poorer survival after adjustment for gender and age were non-surgical treatments (HRadj=1.88;95%CI=1.45-2.45),
advanced stage (III+IV) (HRadj=2.50; 95%CI=2.00-3.12), histological grading in poorly differentiated (HRadj=1.84;
95%CI=1.32-2.56), and Universal Coverage Scheme (HRadj=1.37;95%CI=1.09-1.72). Conclusion: The survival of
colorectal cancer patients in the Universal Coverage Scheme was likely to be poorer than in the Civil Servant Medical
Benefit Scheme. This indicates an urgent need for a national program for colorectal cancer screening in the general
population and access to health insurance.
Identifiants
pubmed: 31244302
doi: 10.31557/APJCP.2019.20.6.1797
pmc: PMC7021590
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1797-1802Références
CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17
pubmed: 24639052
Am J Public Health. 2000 Nov;90(11):1746-54
pubmed: 11076244
J Med Assoc Thai. 2010 Oct;93(10):1156-66
pubmed: 20973318
Lancet Oncol. 2010 Feb;11(2):165-73
pubmed: 20005175
Best Pract Res Clin Gastroenterol. 2015 Dec;29(6):953-65
pubmed: 26651256
J Med Assoc Thai. 2012 Jul;95 Suppl 7:S196-200
pubmed: 23130454
Cancer. 2010 Sep 1;116(17):4178-86
pubmed: 20549764
BMC Cancer. 2017 May 18;17(1):339
pubmed: 28521746
Soc Sci Med. 2000 May;50(9):1197-208
pubmed: 10728841
Cancer Med. 2013 Jun;2(3):403-11
pubmed: 23930216
Asian Pac J Cancer Prev. 2016;17(4):2055-60
pubmed: 27221895
Cancer. 2014 Sep 15;120(18):2810-3
pubmed: 24895320
Int J Health Geogr. 2004 Sep 29;3(1):21
pubmed: 15456514
J Formos Med Assoc. 2018 May;117(5):358-364
pubmed: 28988890
J Clin Oncol. 2009 Aug 1;27(22):3627-33
pubmed: 19470927
Am J Gastroenterol. 2008 Jun;103(6):1488-95
pubmed: 18510616
Dis Colon Rectum. 2010 Jan;53(1):9-15
pubmed: 20010344
IARC Sci Publ. 2011;(162):257-91
pubmed: 21675431
Arch Intern Med. 2003 Oct 13;163(18):2135-44
pubmed: 14557210
Int J Cancer. 2012 Oct 1;131(7):1649-58
pubmed: 21607946
J Epidemiol. 2017 Mar;27(3S):S36-S42
pubmed: 28214186
World J Gastroenterol. 2009 Dec 21;15(47):5907-15
pubmed: 20014454
Curr Gastroenterol Rep. 2017 Aug 10;19(10):47
pubmed: 28799068
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Oncotarget. 2016 Aug 9;7(32):52095-52103
pubmed: 27437765
Bull World Health Organ. 2004 Oct;82(10):750-6
pubmed: 15643796
Int J Environ Res Public Health. 2015 Dec 22;13(1):ijerph13010048
pubmed: 26703651